Followers | 123 |
Posts | 16770 |
Boards Moderated | 1 |
Alias Born | 07/21/2006 |
Friday, January 22, 2021 1:37:25 PM
Recent PASG News
- Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 11:00:15 AM
- Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference • GlobeNewswire Inc. • 10/24/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:41:45 PM
- Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:00:19 AM
- Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024) • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Passage Bio Welcomes Tom Kassberg to Board of Directors • GlobeNewswire Inc. • 09/10/2024 11:52:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:00:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:11 PM
- Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/09/2024 09:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:00:22 AM
- Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:47 AM
- Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:01:19 AM
- Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:52:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:03:29 PM
- Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM